ArticleMolecular medicine (Cambridge, Mass.)2019

miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease.

Jun-Ke Long et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.